ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,622.32
1.35%
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs Yen
155.775
0.00%
Brent Oil
82.585
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NYSE
  6. Edwards Lifesciences Corp (EW)

  7. Edwards Lifesciences Corp (EW) ニュース

EW

Edwards Lifesciences (EW)

Edwards Lifesciences Corp
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:EW
日付受信時刻ニュースソース見出しコード企業名
2024/05/1105 : 07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/1008 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/0918 : 13Business WireEdwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vorNYSE:EWEdwards Lifesciences Corp
2024/05/0918 : 13Business WireEdwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilitéNYSE:EWEdwards Lifesciences Corp
2024/05/0908 : 21Business WireEdwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance DurabilityNYSE:EWEdwards Lifesciences Corp
2024/05/0905 : 52Edgar (US Regulatory)Form 8-K - Current reportNYSE:EWEdwards Lifesciences Corp
2024/05/0806 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/0806 : 47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/0805 : 12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/0708 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/0708 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/0708 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/0708 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
2024/05/0708 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
 Showing the most relevant articles for your search:NYSE:EW

最近閲覧した銘柄

TSXV
MCV
AMEX
VTRO
Vitro Biopharma
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有